Works matching IS 02780232 AND DT 2021 AND VI 39 AND IP 1

Results: 20

A real‐world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 41, doi. 10.1002/hon.2820

By:

Rocchi, Serena;
Tacchetti, Paola;
Pantani, Lucia;
Mancuso, Katia;
Rizzello, Ilaria;
di Giovanni Bezzi, Chiara;
Scalese, Marco;
Dozza, Luca;
Marzocchi, Giulia;
Martello, Marina;
Barilà, Gregorio;
Antonioli, Elisabetta;
Staderini, Michela;
Buda, Gabriele;
Petrini, Mario;
Cea, Michele;
Quaresima, Micol;
Furlan, Anna;
Bonalumi, Angela;
Cavo, Michele

Publication type:

Article

Extended follow‐up of CD4<sup>+</sup> T cell recovery kinetics in a large cohort of patients with B‐cell lymphoproliferative disease treated with rituximab‐bendamustine.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 137, doi. 10.1002/hon.2797

By:

Gaiolla, Rafael;
Hartley, Sarah;
Beech, Amy;
Knight, Helen;
Smith, Dean;
Bishton, Mark;
Fox, Christopher P.;
Martinez‐Calle, Nicolas

Publication type:

Article

B cell receptor signaling related to resistance to Helicobacter pylori eradication therapy in gastric diffuse large B cell lymphoma.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 145, doi. 10.1002/hon.2816

By:

Torisu, Takehiro;
Kawano, Shinichi;
Miyawaki, Kohta;
Yamamoto, Hidetaka;
Ihara, Yutaro;
Matsuno, Yuichi;
Torisu, Kumiko;
Sugio, Takeshi;
Sasaki, Kensuke;
Shimakawa, Takashi;
Kato, Koji;
Akashi, Koichi;
Nakamura, Shotaro;
Kitazono, Takanari

Publication type:

Article

Demyelinating brain lesions developing in a patient with chronic lymphocytic leukemia shortly after treatment with a fludarabine containing regimen.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 129, doi. 10.1002/hon.2815

By:

Kreiniz, Natalia;
Garty‐Ofir, Maya;
Bejar, Jacob;
Polliack, Aaron;
Tadmor, Tamar

Publication type:

Article

A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B‐cell lymphomas.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 60, doi. 10.1002/hon.2822

By:

Vannata, Barbara;
Vanazzi, Anna;
Negri, Mara;
Liptrott, Sarah Jayne;
Bartosek, Anna Amalia;
Miani, Monica;
Di Sanzo, Alessandro;
Cavalli, Franco;
Zucca, Emanuele;
Stathis, Anastasios

Publication type:

Article

The tumor microenvironment of lymphomas: Insights into the potential role and modes of actions of checkpoint inhibitors.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 3, doi. 10.1002/hon.2821

By:

Menter, Thomas;
Tzankov, Alexandar;
Dirnhofer, Stefan

Publication type:

Article

Increase of immunoglobulin A during ibrutinib therapy reduces infection rate in chronic lymphocytic leukemia patients.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 141, doi. 10.1002/hon.2814

By:

Cassin, Ramona;
Visentin, Andrea;
Giannarelli, Diana;
Noto, Alessandro;
Mauro, Francesca Romana;
Baldini, Luca;
Trentin, Livio;
Reda, Gianluigi

Publication type:

Article

Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 123, doi. 10.1002/hon.2808

By:

Iurlo, Alessandra;
Palandri, Francesca;
Maria Elli, Elena;
Cattaneo, Daniele;
Bucelli, Cristina;
Sciumè, Mariarita;
Vincelli, Donatella;
Brioschi, Filippo;
Auteri, Giuseppe;
Croci, Giorgio Alberto;
Guerneri, Silvana;
Isimbaldi, Giuseppe;
Sabattini, Elena;
Cortinovis, Ivan;
Bossi, Anna;
Rosti, Vittorio;
Martino, Bruno;
Baldini, Luca;
Gianelli, Umberto

Publication type:

Article

Diagnostic strategy for trigger identification in severe reactive hemophagocytic lymphohistiocytosis: A diagnostic accuracy study.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 114, doi. 10.1002/hon.2819

By:

Tudesq, Jean‐Jacques;
Valade, Sandrine;
Galicier, Lionel;
Zafrani, Lara;
Boutboul, David;
de Bazelaire, Cédric;
Munoz‐Bongrand, Nicolas;
Canet, Emmanuel;
Ardisson, Fanny;
Lemiale, Virginie;
Darmon, Michael;
Azoulay, Elie;
Mariotte, Eric

Publication type:

Article

Clinical trial risk in leukemia: Biomarkers and trial design.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 105, doi. 10.1002/hon.2818

By:

Li, Alice J.;
Dhanraj, Jasper P.;
Lopes, Gilberto;
Parker, Jayson L.

Publication type:

Article

Recent advances in chimeric antigen receptor natural killer cell therapy for overcoming intractable hematological malignancies.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 11, doi. 10.1002/hon.2802

By:

Tanaka, Junji

Publication type:

Article

Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 97, doi. 10.1002/hon.2813

By:

Betticher, Christophe;
Bacher, Ulrike;
Legros, Myriam;
Zimmerli, Stefan;
Banz, Yara;
Mansouri Taleghani, Behrouz;
Pabst, Thomas

Publication type:

Article

Consolidation with <sup>90</sup>Yttrium‐ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 51, doi. 10.1002/hon.2809

By:

Miura, Katsuhiro;
Tsujimura, Hideki;
Masaki, Yasufumi;
Iino, Masaki;
Takizawa, Jun;
Maeda, Yoshinobu;
Yamamoto, Kazuhiko;
Tamura, Shinobu;
Yoshida, Akiyo;
Yagi, Hideo;
Yoshida, Isao;
Kitazume, Koichi;
Masunari, Taro;
Choi, Ilseung;
Kakinoki, Yasutaka;
Suzuki, Ritsuro;
Yoshino, Tadashi;
Nakamura, Shigeo;
Hatta, Yoshihiro;
Yoshida, Takashi

Publication type:

Article

Rescue of chemorefractory classical Hodgkin lymphoma with nivolumab and autologous stem‐cell transplantation: Real‐life experience.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 134, doi. 10.1002/hon.2796

By:

Buccheri, Valeria;
Fatobene, Giancarlo;
Santos, Fernanda M.;
Velasques, Rodrigo D.;
Bellesso, Marcelo;
Atanazio, Marcelo J.;
Rocha, Vanderson

Publication type:

Article

Outcomes of second hematopoietic stem cell transplantation using reduced‐intensity conditioning in an outpatient setting.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 87, doi. 10.1002/hon.2812

By:

Jaime‐Pérez, José Carlos;
Picón‐Galindo, Ernesto;
Herrera‐Garza, José Luis;
Gómez‐Almaguer, David

Publication type:

Article

Hematopoietic stem cell transplantation for diffuse large B‐cell lymphoma having 8q24/MYC rearrangement in Japan.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 66, doi. 10.1002/hon.2811

By:

Takahashi, Tsutomu;
Suzuki, Ritsuro;
Yamamoto, Go;
Nakazawa, Hideyuki;
Kurosawa, Mitsutoshi;
Kobayashi, Tsutomu;
Okada, Masaya;
Akasaka, Takashi;
Kim, Sung‐Won;
Fukuda, Takahiro;
Ichinohe, Tatsuo;
Atsuta, Yoshiko;
Suzumiya, Junji

Publication type:

Article

Management of patients with acute myeloid leukemia undergoing therapy with midostaurin: a focus on antifungal prophylaxis.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 20, doi. 10.1002/hon.2788

By:

Cairoli, Roberto;
Ferrara, Felicetto;
Girmenia, Corrado;
Luppi, Mario;
Pea, Federico;
Specchia, Giorgina;
Venditti, Adriano

Publication type:

Article

The role of long non‐coding RNAs and downstream signaling pathways in leukemia progression.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 27, doi. 10.1002/hon.2776

By:

Liu, Yadong;
Sun, Penghao;
Zhao, Yuhao;
Liu, Bin

Publication type:

Article

Humanized anti‐CD19 chimeric antigen receptor‐T cell therapy is safe and effective in lymphoma and leukemia patients with chronic and resolved hepatitis B virus infection.

Published in:

Hematological Oncology, 2021, v. 39, n. 1, p. 75, doi. 10.1002/hon.2807

By:

Cui, Rui;
Lyu, Cuicui;
Li, Qing;
Jiang, Yanyu;
Mou, Nan;
Yang, Zhenxing;
Liu, Xuxiang;
Deng, Qi;
Li, Lanfang

Publication type:

Article

Issue Information.

Published in:: Hematological Oncology, 2021, v. 39, n. 1, p. 1, doi. 10.1002/hon.2745
Publication type:: Article